• Cures Platform
What we’re working on
The Cures Platform naturally breaks down current data silos, creating a robust data set beneficial and accessible to all stakeholders.
Nano-Arm Holdings developed CureBot devices enable molecular data capture and predictive analytics for Self-Driving Cures.
This approach dramatically shortens traditional Cure development timelines and related costs.
• Cures Platform
Lab to market
We need faster, more cost effective and, most importantly, highly accessible approaches to cure development and distribution.
Our in-development lab-to-market framework will feature self-administered therapeutics and vaccine technologies that will be available both online and through direct-to-consumer channels such as online, pharmacies and urgent-care centers.
• Cures Platform
Delivery mechanisms
At Nano, we have a deep admiration and respect for the history of drug and vaccine development, but we’re not confined by conventional distribution.
While many vaccines and medications will continue to be delivered via traditional syringes and pills, Nano's vision for delivery mechanisms includes nasal sprays, inhalation and topical creams, for example. In addition, vaccines and therapeutics will be delivered through innovative transport such as drones, when applicable.
• Cures Platform
Delivery mechanisms
At Nano, we have a deep admiration and respect for the history of drug and vaccine development, but we’re not confined by conventional distribution.
While many vaccines and medications will continue to be delivered via traditional syringes and pills, Nano's vision for delivery mechanisms includes nasal sprays, inhalation and topical creams, for example. In addition, vaccines and therapeutics will be delivered through innovative transport such as drones, when applicable.